Eso Technologies is a biotechnology and healthcare startup founded in 2008. The company's slogan, "Minimally invasive, safe, and accurate esophageal cardiac monitoring—advancing cardiac care for surgical and ICU patients," reflects its focus on developing innovative medical devices. Eso Technologies is guided by a knowledgeable management team and is currently creating an esophageal cardiac vital signs monitoring system that offers a compelling alternative to current invasive devices. Clinical studies have demonstrated its effectiveness in expanding the capabilities of cardiac care for patients in surgical and ICU settings.
The company recently received a $590.00K Venture Round investment on 24 May 2016, signifying investor confidence in its innovative approach to cardiac monitoring technology. The specific investors involved in this round are not disclosed publicly. Eso Technologies' focus on minimally invasive and accurate monitoring solutions positions it at the forefront of advancing cardiac care, with potential for significant impact in the medical device industry.
Philips BioTel Heart